Present and future of cancer immunotherapy: A tumor microenvironmental perspective (Review)
Open Access
- 26 July 2018
- journal article
- review article
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (4), 4105-4113
- https://doi.org/10.3892/ol.2018.9219
Abstract
Modulation of the tumor microenvironment is becoming an increasingly popular research topic in the field of immunotherapy, and studies regarding immune checkpoint blockades and cancer immunotherapy have pushed cancer immunotherapy to a climax. Simultaneously, the manipulation of the immune regulatory pathway can create an effective immunotherapy strategy; however, the tumor microenvironment serves an important role in suppressing the antitumor immunity by its significant heterogeneity. A number of patients with cancer do not have a good response to monotherapy approaches; therefore, combination strategies are required to achieve optimal therapeutic benefits. Targeting the tumor microenvironment may provide a novel strategy for immunotherapy, break down the resistance of conventional cancer therapy and produce the foundation for personalized precision medicine. The present review summarized the research regarding cancer immunotherapy from the perspective of how the tumor microenvironment affects the immune response, with the aim of proposing a novel strategy for cancer immunotherapy and combination therapy.Keywords
This publication has 92 references indexed in Scilit:
- The Pancreas Cancer MicroenvironmentClinical Cancer Research, 2012
- Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T LymphocytesCancer Research, 2012
- Normalization of the Vasculature for Treatment of Cancer and Other DiseasesPhysiological Reviews, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and HumansScience, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaThe New England Journal of Medicine, 2010
- Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progressionSeminars in Cell & Developmental Biology, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT–PCR mRNA expression profileBritish Journal of Cancer, 2007
- Fibroblasts in cancerNature Reviews Cancer, 2006